Urological Oncology: New Insights into Diagnosis and Treatment

Dear Colleagues,

Urological oncology is a constantly evolving field. Each year brings forward new insights into diagnostic methods and treatment approaches, encompassing surgical techniques, chemotherapy, immunotherapy, and radiotherapeutic strategies, which significantly influence clinical practice and shape guideline recommendations.

The scope of these innovations is consistently focused on maximizing benefits related to oncological outcomes, including overall survival, recurrence-free survival, quality of life, functional outcomes, among others. Precision in diagnostic methods is continually improving, as seen in techniques such as MRI–ultrasound prostate fusion biopsy, MRI in muscle-invasive cancer, and prostate cancer diagnosis. Surgical techniques have made significant progress over the past decade, with a focus on minimally invasive procedures that seek to achieve precise treatment while preserving function; examples include ultrapreservative radical prostatectomy, totally clampless partial nephrectomy, and totally intracorporeal urinary diversions and neobladders. Regarding medical and radiological therapies, new strategies are constantly emerging and being studied with regard to neoadjuvant or adjuvant therapy indications, with dose adjustments to achieve disease control and reduce side-effects.

Urologic oncology is a comprehensive field, requiring interdisciplinary cooperation with the primary goal of enhancing both quality of life and disease control. This Special Issue is dedicated to publishing contributions centered around innovative strategies in the diagnosis and treatment of urinary tumors, contributing to the growing body of evidence in the field.

Dr. Aldo Brassetti
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.